Eczema is a condition wherein patches of your skin become inflamed, itchy, cracked, rough, and, in some cases, cause blisters.
There is no known cure for eczema. Its symptoms, however, can be remedied as they appear.
Eczema has many types, and the most common is atopic dermatitis. The most common symptoms are dry and scaly skin, skin flushing, itching, and open, crusted, or weeping sores.
Researchers have so far not discovered what specifically causes eczema, but many scientists believed that it occurs when the skin barrier is defective, allowing irritants and allergens to enter and cause an inflammatory response from your body.
Other factors that can trigger the symptoms of eczema are microbes, hot and cold temperatures, food, stress, and hormones.
To prevent frequent flare-ups, you must avoid food allergens and make sure that your skin is protected all the time.
There is one daily routine that most people do that can be of big help in keeping your skin protected, and that is taking a lukewarm bath daily.
Bathing not only soothes your skin, but it can wash away old creams as well as dead skin that can leave your skin refreshed. Taking a bath can also wash away the bacteria that may cause a flare-up.
And, when you bathe, make sure that you don't use soaps because it can leave your skin dry, which may lead to itching. Instead, use dermatologist-approved body cleansers.
After bathing, make sure that you do not rub your skin dry but instead pat it dry.
And, while your skin is still slightly damp, immediately lather on a moisturizer that is also approved by dermatologists.
It is also important to get a moisturizer that comes with a pump dispenser.
It would also be wise to keep your skin moisturized all throughout the day because, as stated above, dry skin could lead to itchiness.
It is important that you know what triggers your eczema symptoms or flare-ups so you can avoid them beforehand. Also, having this information could help you with how to go about planning your skin protection and treating your symptoms.
Image credit courtesy of Amanda Dalbjörn/Unsplash


Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 



